Department of Bioprocess Development, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), New Borg El-Arab City, Alexandria, 21934, Egypt.
Microbial Biotechnology Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, El Sadat City, Egypt.
Sci Rep. 2022 Nov 18;12(1):19869. doi: 10.1038/s41598-022-24303-5.
Chitosan nanoparticles (CNPs) are promising versatile cationic polymeric nanoparticles, which have received growing interest over last few decades. The biocompatibility, biodegradability, environmental safety and non-toxicity of the chitosan nanoparticles makes it preferred for a wide range of biological applications including agriculture, medical and pharmaceutical fields. In this study, CNPs were biosynthesized by aqueous extract of Eucalyptus globulus Labill fresh leaves as bio-reductant. Box-Behnken design in 29 experimental runs was used for optimization of different factors affecting the production of CNPs. The maximum yield of CNPs was 9.91 mg/mL at pH of 4.5, chitosan concentration of 1%, incubation time of 60 min and temperature of 50 °C. The crystallinity, particle size and morphology of the biosynthesized CNPs were characterized. The CNPs possess a positively charged surface of 31.1 mV. The SEM images of the CNPs confirms the formation of spherical form with smooth surface. The TEM images show CNPs were spherical in shape and their size range was between 6.92 and 10.10 nm. X-ray diffraction indicates the high degree of CNPs crystallinity. FTIR analysis revealed various functional groups of organic compounds including NH, NH, C-H, C-O, C-N, O-H, C-C, C-OH and C-O-C. The thermogravimetric analysis results revealed that CNPs are thermally stable. The antibacterial activity of CNPs was determined against pathogenic multidrug-resistant bacteria, Acinetobacter baumannii. The diameters of the inhibition zones were 12, 16 and 30 mm using the concentrations of 12.5, 25 and 50 mg/mL; respectively. When compared to previous studies, the biosynthesized CNPs produced using an aqueous extract of fresh Eucalyptus globulus Labill leaves have the smallest particle sizes (with a size range between 6.92 and 10.10 nm). Consequently, it is a promising candidate for a diverse range of medical applications and pharmaceutical industries.
壳聚糖纳米颗粒(CNPs)是一种很有前途的多功能阳离子聚合物纳米颗粒,在过去几十年中受到了越来越多的关注。壳聚糖纳米颗粒具有生物相容性、可生物降解性、环境安全性和低毒性,因此它被广泛应用于农业、医学和制药等领域。在本研究中,我们使用新鲜的桉树叶水提物作为生物还原剂来生物合成 CNPs。通过 29 次实验运行的 Box-Behnken 设计,优化了影响 CNPs 生产的不同因素。在 pH 值为 4.5、壳聚糖浓度为 1%、孵育时间为 60 min 和温度为 50°C 的条件下,CNPs 的最大产率为 9.91 mg/mL。对生物合成的 CNPs 的结晶度、粒径和形态进行了表征。CNPs 具有 31.1 mV 的正表面电荷。CNPs 的 SEM 图像证实了其形成了具有光滑表面的球形。TEM 图像显示,CNPs 呈球形,其粒径范围在 6.92 和 10.10nm 之间。X 射线衍射表明 CNPs 具有较高的结晶度。FTIR 分析表明,有机化合物存在各种官能团,包括 NH、NH、C-H、C-O、C-N、O-H、C-C、C-OH 和 C-O-C。热重分析结果表明,CNPs 具有热稳定性。测定了 CNPs 对致病性多重耐药菌鲍曼不动杆菌的抗菌活性。浓度为 12.5、25 和 50mg/mL 时,抑菌圈直径分别为 12、16 和 30mm。与之前的研究相比,使用新鲜桉树叶水提物生物合成的 CNPs 的粒径最小(粒径范围在 6.92 和 10.10nm 之间)。因此,它是医学应用和制药行业的一个很有前途的候选者。